
Austin Murata
Examiner (ID: 10706, Phone: (571)270-5596 , Office: P/1712 )
| Most Active Art Unit | 1712 |
| Art Unit(s) | 1792, 1712 |
| Total Applications | 876 |
| Issued Applications | 484 |
| Pending Applications | 86 |
| Abandoned Applications | 318 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6912346
[patent_doc_number] => 20050176104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Compositions and methods for the treatment of tumor'
[patent_app_type] => utility
[patent_app_number] => 11/052503
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 56434
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176104.pdf
[firstpage_image] =>[orig_patent_app_number] => 11052503
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/052503 | Compositions and methods for the treatment of tumor | Feb 3, 2005 | Abandoned |
Array
(
[id] => 6951791
[patent_doc_number] => 20050226885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Cytolysis of target cells by superantigen conjugates inducing T-cell activation'
[patent_app_type] => utility
[patent_app_number] => 11/023086
[patent_app_country] => US
[patent_app_date] => 2004-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15641
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20050226885.pdf
[firstpage_image] =>[orig_patent_app_number] => 11023086
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/023086 | Cytolysis of target cells by superantigen conjugates inducing T-cell activation | Dec 26, 2004 | Abandoned |
Array
(
[id] => 903693
[patent_doc_number] => 07335744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-26
[patent_title] => 'Prostate cancer specific internalizing human antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/021438
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23003
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/335/07335744.pdf
[firstpage_image] =>[orig_patent_app_number] => 11021438
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/021438 | Prostate cancer specific internalizing human antibodies | Dec 20, 2004 | Issued |
Array
(
[id] => 4797452
[patent_doc_number] => 20080009038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Methods for Enhancing Antibody Activity'
[patent_app_type] => utility
[patent_app_number] => 10/582413
[patent_app_country] => US
[patent_app_date] => 2004-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12105
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009038.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582413
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582413 | Methods for Enhancing Antibody Activity | Dec 9, 2004 | Abandoned |
Array
(
[id] => 7039319
[patent_doc_number] => 20050158753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Reagents and methods useful for detecting diseases of the gastrointestinal tract'
[patent_app_type] => utility
[patent_app_number] => 11/007835
[patent_app_country] => US
[patent_app_date] => 2004-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 36829
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158753.pdf
[firstpage_image] =>[orig_patent_app_number] => 11007835
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/007835 | Reagents and methods useful for detecting diseases of the gastrointestinal tract | Dec 7, 2004 | Abandoned |
Array
(
[id] => 7038889
[patent_doc_number] => 20050158323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells'
[patent_app_type] => utility
[patent_app_number] => 11/003819
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 58650
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158323.pdf
[firstpage_image] =>[orig_patent_app_number] => 11003819
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/003819 | Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells | Dec 5, 2004 | Abandoned |
Array
(
[id] => 7097232
[patent_doc_number] => 20050129690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/996316
[patent_app_country] => US
[patent_app_date] => 2004-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 17236
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20050129690.pdf
[firstpage_image] =>[orig_patent_app_number] => 10996316
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/996316 | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof | Nov 22, 2004 | Issued |
Array
(
[id] => 4639708
[patent_doc_number] => 08017735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-13
[patent_title] => 'Anti-IGFR1 antibody therapeutic combinations'
[patent_app_type] => utility
[patent_app_number] => 10/993395
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21741
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/017/08017735.pdf
[firstpage_image] =>[orig_patent_app_number] => 10993395
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/993395 | Anti-IGFR1 antibody therapeutic combinations | Nov 18, 2004 | Issued |
Array
(
[id] => 7689534
[patent_doc_number] => 20070105164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Cancer diagnosis and therapy'
[patent_app_type] => utility
[patent_app_number] => 10/579168
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4805
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105164.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579168
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579168 | Cancer diagnosis and therapy | Nov 14, 2004 | Abandoned |
Array
(
[id] => 5248070
[patent_doc_number] => 20070244304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Methods of Identifying Neoplasm-Specific Antibodies and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/579107
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17674
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20070244304.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579107
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579107 | Methods of Identifying Neoplasm-Specific Antibodies and Uses Thereof | Nov 11, 2004 | Abandoned |
Array
(
[id] => 7103888
[patent_doc_number] => 20050106614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Reagents and methods useful for detecting diseases of the prostate'
[patent_app_type] => utility
[patent_app_number] => 10/988091
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 36456
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106614.pdf
[firstpage_image] =>[orig_patent_app_number] => 10988091
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/988091 | Reagents and methods useful for detecting diseases of the prostate | Nov 11, 2004 | Abandoned |
Array
(
[id] => 5480029
[patent_doc_number] => 20090202986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'METHODS OF OPTIMIZING ANTIBODY VARIABLE REGION BINDING AFFINITY'
[patent_app_type] => utility
[patent_app_number] => 11/577061
[patent_app_country] => US
[patent_app_date] => 2004-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27412
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202986.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577061
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577061 | METHODS OF OPTIMIZING ANTIBODY VARIABLE REGION BINDING AFFINITY | Oct 27, 2004 | Abandoned |
Array
(
[id] => 5253286
[patent_doc_number] => 20070134742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Diagnostic reagent for uterine adenocarcinoma and method of detecting adenocarcinoma cells'
[patent_app_type] => utility
[patent_app_number] => 10/577427
[patent_app_country] => US
[patent_app_date] => 2004-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3672
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134742.pdf
[firstpage_image] =>[orig_patent_app_number] => 10577427
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577427 | Diagnostic reagent for uterine adenocarcinoma and method of detecting adenocarcinoma cells | Oct 24, 2004 | Abandoned |
Array
(
[id] => 5596178
[patent_doc_number] => 20060160095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Survivin'
[patent_app_type] => utility
[patent_app_number] => 10/972576
[patent_app_country] => US
[patent_app_date] => 2004-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 19258
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160095.pdf
[firstpage_image] =>[orig_patent_app_number] => 10972576
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/972576 | Survivin | Oct 24, 2004 | Abandoned |
Array
(
[id] => 7128062
[patent_doc_number] => 20050059806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Nucleic acid encoding anti-IgE antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/968237
[patent_app_country] => US
[patent_app_date] => 2004-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21543
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10968237
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/968237 | Nucleic acid encoding anti-IgE antibodies | Oct 18, 2004 | Issued |
Array
(
[id] => 4772609
[patent_doc_number] => 20080058268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Methods and Agents for the Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 10/575736
[patent_app_country] => US
[patent_app_date] => 2004-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 15067
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20080058268.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575736
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575736 | Methods and Agents for the Treatment of Cancer | Oct 14, 2004 | Abandoned |
Array
(
[id] => 4943720
[patent_doc_number] => 20080081045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-03
[patent_title] => 'Combination Therapy for Cancer'
[patent_app_type] => utility
[patent_app_number] => 10/575618
[patent_app_country] => US
[patent_app_date] => 2004-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19425
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20080081045.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575618
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575618 | Combination Therapy for Cancer | Oct 13, 2004 | Abandoned |
Array
(
[id] => 7192665
[patent_doc_number] => 20050163709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes'
[patent_app_type] => utility
[patent_app_number] => 10/955119
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 29906
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163709.pdf
[firstpage_image] =>[orig_patent_app_number] => 10955119
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/955119 | Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes | Sep 29, 2004 | Abandoned |
Array
(
[id] => 6939148
[patent_doc_number] => 20050112711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Diagnosis and monitoring of hepatocellular carcinoma'
[patent_app_type] => utility
[patent_app_number] => 10/934520
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6754
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934520
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934520 | Diagnosis and monitoring of hepatocellular carcinoma | Sep 2, 2004 | Abandoned |
Array
(
[id] => 7252119
[patent_doc_number] => 20050074798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancer'
[patent_app_type] => utility
[patent_app_number] => 10/917517
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15717
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10917517
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/917517 | Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancer | Aug 12, 2004 | Abandoned |